Pfizer's oral anti-viral Covid-19 treatment Paxlovid has won full approval from the US Food and Drug Administration (FDA) after Emergency Use Authorization was granted in...

The market value of US vaccine maker Novavax is gaining momentum again on the back of promising data the company recently provided on its combined Covid and flu vaccine...

All immediate challenges to the status of abortifacient mifepristone on the US market are on ice for the near future after the Supreme Court on Apr. 21 — without...

All changes to the US use of abortifacient mifepristone are now on hold – for three more days – pending a review by Supreme Court Justice Samuel Alito of two complex and...

At the beginning of 2023, the US Food and Drug Administration (FDA) stepped into a political hornet’s nest with its decision to allow retail pharmacies to dispense...

Catalent has opened a new commercial-scale cell therapy manufacturing facility at its European center of excellence for cell therapies in Gosselies, Belgium.

US drugs giant Merck & Co has granted Sinopharm exclusive import and distribution rights to its oral Covid treatment Lagevrio (molnupiravir) in China.

Days before the FDA approved the new bivalent Covid-19 vaccine boosters, Pascal Soriot, CEO of AstraZeneca, offered his own assessment of the need for such.